G1 Therapeutics

Description

Develops and delivers cancer therapies for people living with cancer, with a focus on optimizing chemotherapy, advancing survival, and supporting scientific publications.

G1 Therapeutics is located in the Research Triangle ecosystem.

Related

• Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
• Karyopharm Therapeutics ($KPTI)Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high…
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…
• Vivere OncotherapiesDevelops intravenously administered cancer therapies using engineered delivery vehicles that selectively replicate within tumors, target…
• Institute for Systems BiologyConducts systems biology research on cancer, health, infectious disease, chronic illness, and environment, while providing education,…
• March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
• BioNTechBioNTech develops investigational therapies for cancer and infectious diseases, including mRNA cancer immunotherapies, immunomodulators,…
• ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…
• Myriad GeneticsDevelops genetic tests that help clinicians assess inherited cancer risk, choose cancer therapies, guide psychiatric treatment, and monitor…
• Locus BiosciencesDevelops bacteriophage-based precision medicines and microbiome biotherapeutics to target disease-causing bacteria in infections, with…
• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…